Patents Assigned to BLIS Technologies Limited
  • Antiviral treatment comprising Blis containing probiotic products
    Patent number: 12480089
    Abstract: This invention relates to methods of prophylactically or therapeutically treating viral infections particularly in the lower respiratory tract. Treatment of coronavirus infections is particularly contemplated. The invention also relates to the use of BLIS-producing Streptococcus strains, extracts and exudates thereof, and compositions containing same in the prevention, reduction, or treatment of such virus infections.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: November 25, 2025
    Assignee: BLIS TECHNOLOGIES LIMITED
    Inventors: John David Francis Hale, John Robert Tagg
  • PROBIOTIC ENHANCERS AND USES THEREOF
    Publication number: 20240390434
    Abstract: Described herein is a method of improving the inhibitory profile of Streptococcus salivarius comprising formulating the S. salivarius in a composition comprising an effective amount of a supplemental saccharide. Also described herein are compositions comprising Streptococcus salivarius and supplemental saccharide, methods of inhibiting microorganisms using such compositions, therapeutic formulations comprising such compositions, and methods of treating or preventing diseases using such compositions and therapeutic formulations.
    Type: Application
    Filed: September 30, 2022
    Publication date: November 28, 2024
    Applicant: Blis Technologies Limited
    Inventors: Nicola Jones, John David Hale, John Tagg, Rohit Jain, Liam Karl Harold
  • ANTIVIRAL TREATMENT COMPRISING BLIS CONTAINING PROBIOTIC PRODUCTS
    Publication number: 20230303964
    Abstract: This invention relates to methods of prophylactically or therapeutically treating viral infections particularly in the lower respiratory tract. Treatment of coronavirus infections is particularly contemplated. The invention also relates to the use of BLIS-producing Streptococcus strains, extracts and exudates thereof, and compositions containing same in the prevention, reduction, or treatment of such virus infections.
    Type: Application
    Filed: March 31, 2021
    Publication date: September 28, 2023
    Applicant: BLIS TECHNOLOGIES LIMITED
    Inventors: John David Francis Hale, John Robert Tagg
  • Skin treatment compositions
    Patent number: 8283136
    Abstract: This invention relates to Micrococcus luteus containing compositions useful for controlling skin disorders in which bacteria are a causative component. The invention also provides for a new strain of Micrococcus luteus useful in these compositions.
    Type: Grant
    Filed: February 23, 2010
    Date of Patent: October 9, 2012
    Assignee: Blis Technologies Limited
    Inventors: John Robert Tagg, Christopher Norman Chilcott, Mohammed Abdullah Ali Alqumber
  • Treatment of malodour
    Patent number: 8057790
    Abstract: This invention relates to methods for inhibiting growth of anaerobic bacteria, particularly halitosis causing bacteria. The methods use BLIS-producing Streptococcus salivarius strains, extracts thereof, and compositions comprising same in the prevention or treatment of halitosis.
    Type: Grant
    Filed: September 25, 2009
    Date of Patent: November 15, 2011
    Assignee: Blis Technologies Limited
    Inventors: John Robert Tagg, Christopher Norman Chilcott, Jeremy Paul Burton
  • Treatment of malodour
    Patent number: 7595041
    Abstract: This invention relates to methods for inhibiting growth of anaerobic bacteria, particularly halitosis causing bacteria. The methods use BLIS-producing Streptococcus salivarius strains, extracts thereof, and compositions comprising same in the prevention or treatment of halitosis.
    Type: Grant
    Filed: July 19, 2004
    Date of Patent: September 29, 2009
    Assignee: BLIS Technologies Limited
    Inventors: John Robert Tagg, Christopher Norman Chilcott, Jeremy Paul Burton
  • Antimicrobial composition
    Patent number: 7226590
    Abstract: This invention provides novel Streptococcus salivarius, compositions containing same, and use of S. salivarius strains as antimicrobial agents. The strains are bacterial inhibitors with respect to at least S. mutans and/or MS and therefore have a number of therapeutic applications. The applications include but are not limited to forming part of therapeutic formulations for use in controlling, treating, or preventing dental caries.
    Type: Grant
    Filed: February 21, 2003
    Date of Patent: June 5, 2007
    Assignee: BLIS Technologies Limited
    Inventors: Christopher Norman Chilcott, John Robert Tagg
  • Lantibiotic
    Patent number: 6773912
    Abstract: This invention provides an antibacterial protein, Salivaricin B. Salivaricin B is bacteriocidal with respect to, inter alia, S. pyogenes and therefore has numerous therapeutic applications. These applications include, but are not limited to, forming part of therapeutic formulations for use in treating or preventing streptococcal infections of the throat.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: August 10, 2004
    Assignees: University of Otago, Blis Technologies Limited
    Inventors: John Robert Tagg, Karen Patricia Dierksen, Mathew Upton